Investing Profile

Stephen Squinto

InvestorVC

Chief Investment Officer, JP Morgan Life Sciences Private Capital at J.P. Morgan Asset Management

orbimed.comNew York, New York

Your Intro Paths to Stephen Squinto

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Stephen is a member of

Hotmail Network

5844 CONNECTIONS

OrbiMed Network

39 CONNECTIONS

OrbiMed Network

39 CONNECTIONS

Loyola University Chicago Network

15 CONNECTIONS

J.P. Morgan Asset Management Network

14 CONNECTIONS

Find Stephen Squinto on

Current Investing Position

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

Stephen Squinto is on these Sector & Stage Rankings

Stephen Squinto's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Enlaza Therapeutics	Series AApr 2024$100M	$160M
Co-investors: James N. Topper (Decheng Capital), Marcos Milla (Samsara BioCapital), Jay Lichter (Madrona Venture Group)
Vanqua Bio	Series BSep 2021$85M	$85M
Co-investors: Jonathan Silverstein (OrbiMed), Bernard Davitian (Omega Funds), Mona Ashiya (OrbiMed Advisors), Sara Nayeem (Avoro Ventures)
iECURE	Series ASep 2021$50M	$120M
Co-investors: Tom Woiwode (Versant Ventures)
Gennao Bio	Series AMay 2021$40M	$40M
Co-investors: Chau Khuong (Catalio Capital Management)
Chemomab	Post Ipo EquityMar 2021$46M	$76M
Co-investors: Fabian Hansen (Presight Capital), Peter Thiel (The Founders Fund)
Gemini Therapeutics	Post Ipo EquityFeb 2021$95M Series AOct 2017$43M SeedApr 2016$2M	$140M
Co-investors: Carl Gordon (OrbiMed Advisors), Jean George (Advanced Technology Ventures), Jason Rhodes (Atlas Venture)
Compass Therapeutics	Series UnknownJun 2020$60M	$160M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Carl Gordon (OrbiMed Advisors), Julie Sunderland (Biomatics Capital Partners), George Godula (NutriSense), Ben Auspitz (Curie.Bio), Peter Thiel (The Founders Fund), Phil Ferneau (Borealis Ventures)
Passage Bio	Series AFeb 2019$120M	$230M
Co-investors: Liam Ratcliffe (New Leaf Venture Partners), Patrick Heron (Frazier Healthcare Partners), Carl Gordon (OrbiMed Advisors), Tom Woiwode (Versant Ventures)

Stephen Squinto's Experience

Executive Partner HotmailPresent

Senior Leadership, Early Company Builder RegeneronPresent

Senior Leadership Discovery Research Regeneron Pharmaceuticals, Inc.Present

Executive Chairman Gennao BioPresent

Chief Investment Officer, JP Morgan Life Sciences Private Capital J.P. Morgan Asset ManagementPresent

Co-Founder; Exec VP, Head of R&D Alexion Pharmaceuticals, Inc.Present

Venture Partner OrbiMedPresent

Executive Partner OrbiMedPresent

Executive Partner OrbiMed AdvisorsPresent

Chairman and CEO Gennao BioPresent

Stephen Squinto's Education

Loyola University Chicago Doctor of Philosophy (Ph.D.), Biochemistry Biochemistry

Loyola University of Chicago Doctor of Philosophy (Ph.D.) Biochemistry

Investors who invest with Stephen Squinto

Scouts & Angels Affiliated With Stephen Squinto